TCBWMS
AZN icon

Texas Capital Bank Wealth Management Services’s AstraZeneca AZN Stock Holding History

Texas Capital Bank Wealth Management Services’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$319K Hold
1,705
– – 0.02% 282
2026
Q1 		$330K Sell
1,705
-3
-0.2% -$578 0.02% 259
2025
Q4 		$314K Buy
+1,708
New +$300K 0.02% 252
2024
Q3 		– Sell
-1,575
Closed -$246K – 207
2024
Q2 		$246K Hold
1,575
– – 0.03% 170
2024
Q1 		$213K Buy
+1,575
New +$209K 0.02% 178

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Texas Capital Bank Wealth Management Services's AZN Position: Q2 2026 in Review

Texas Capital Bank Wealth Management Services held its AstraZeneca (AZN) position steady in Q2 2026 at 1,705 shares worth $319K. The position accounts for 0.02% of the portfolio, ranked #282.

Texas Capital Bank Wealth Management Services first reported a position in AZN in Q1 2024 and has held it in 5 quarters since. The position peaked at $330K in Q1 2026. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Texas Capital Bank Wealth Management Services held 1,705 shares of AstraZeneca worth $319K as of Q2 2026.
  • Texas Capital Bank Wealth Management Services left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.02% of Texas Capital Bank Wealth Management Services's portfolio in Q2 2026, its #282 holding.
  • Texas Capital Bank Wealth Management Services first reported a position in AstraZeneca in Q1 2024 and has held it in 5 quarters since.
  • Texas Capital Bank Wealth Management Services's AstraZeneca position peaked at $330K in Q1 2026.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Texas Capital Bank Wealth Management Services's 13F filing for Q2 2026, filed 7 Aug 2026.